Skip to main navigation Skip to main content
info(at)avldigital.remove-this.de
Deutsch English
Narrow Search
Search narrowed by
Last searches

Results for *

Displaying results 1 to 2 of 2.

  1. Analysis of COVID-related patents for antibodies and vaccines
    Author: Santhanam, Kausalya
    Published: [2023]
    Publisher:  South Centre, Geneva, Switzerland

    This paper provides an analysis of patents covering selected antibodies and vaccines used in the treatment or prevention of COVID-19. The aim of the report is to support national patent offices and interested parties in developing countries with... more

    Access:
    Verlag (kostenfrei)
    Verlag (kostenfrei)
    Resolving-System (kostenfrei)

    Location:
    ZBW - Leibniz-Informationszentrum Wirtschaft, Standort Kiel
    Signature:
    DS 751
    Inter-library loan:
    No inter-library loan

     

    This paper provides an analysis of patents covering selected antibodies and vaccines used in the treatment or prevention of COVID-19. The aim of the report is to support national patent offices and interested parties in developing countries with information that can serve as guidance for the examination of the claims contained in relevant patents or patent applications. The antibody combination considered for the patent analysis in this paper are Casirivimab and Imdevimab. The vaccines considered for the patent analysis are mRNA-1273, Sputnik, ChAdOx1 nCoV-19 vaccine (AZD1222). The analysis was completed in May 2022.

     
    Export to reference management software   RIS file
      BibTeX file
    Source: Union catalogues
    Language: English
    Media type: Book
    Format: Online
    Other identifier:
    hdl: 10419/278404
    Series: Research paper / South Centre ; 173 (7 February 2023)
    Subjects: Access to Medicines; Antibodies; COVID-19; Global Health; Health; Intellectual Property; Pandemic; Patent; Patent Examination; Patent Law; Patent Offices; Patent Policy; Patent Protection; Public Health; Vaccines
    Scope: 1 Online-Ressource (circa 30 Seiten)
  2. Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
    Author: Ravi, Srividya
    Published: [2022]
    Publisher:  South Centre, Geneva, Switzerland

    This report provides an analysis of patents covering medicines in trials to treat COVID-19. The aim of the report is to support national patent offices and interested parties in developing countries with information that can serve as guidance for the... more

    Access:
    Verlag (kostenfrei)
    Verlag (kostenfrei)
    Resolving-System (kostenfrei)

    Location:
    ZBW - Leibniz-Informationszentrum Wirtschaft, Standort Kiel
    Signature:
    DS 751
    Inter-library loan:
    No inter-library loan

     

    This report provides an analysis of patents covering medicines in trials to treat COVID-19. The aim of the report is to support national patent offices and interested parties in developing countries with information that can serve as guidance for the examination of the claims contained in relevant patents or patent applications. The medicines considered for the patent analysis in this report are remdesivir, ruxolitinib, favipiravir, molnupiravir and nirmatrelvir, and the biotherapeutics tocilizumab, siltuximab and sarilumab.

     
    Export to reference management software   RIS file
      BibTeX file
    Source: Union catalogues
    Language: English
    Media type: Book
    Format: Online
    Other identifier:
    hdl: 10419/262128
    Series: Research paper / South Centre ; 153 (26 April 2022)
    Subjects: Access to Medicines; Affordable Medicines; Biotherapeutics; Coronavirus; COVID-19; Favipiravir; Global Health; Health; Intellectual Property; Molnupiravir; Nirmatrelvir; Pandemic; Patent; Patent Offices; Public Health; Remdesivir; Ruxolitinib; Sarilumab; Siltuximab; Tocilizumab
    Scope: 1 Online-Ressource (circa 50 Seiten), Illustrationen